Between May 2013, when Quintiles went public, and this week, newly public companies’ stocks in the biopharma outsourcing space have all seen their prices rise by more than 35%.
Following its recent IPO, INC Research delivered double-digit net service revenue growth for the year and further diversified its customer base when compared with previous years.
A register of clinical investigators can help eliminate bias according to Big Pharma Group Transcelerate, which has teamed with DrugDev to develop such a database.
The integration of Covance and LabCorp is beginning with the announcement that LabCorp will operate under two distinct segments: LabCorp Diagnostics and Covance Drug Development, LabCorp CEO Dave King said in a conference call last week.
MedImmune, the biologics R&D arm of AstraZeneca, and the US National Institute of Standards and Technology (NIST) have signed a five-year agreement to support research that will help advance drug discovery and biomanufacturing.
The China Food and Drug Administration (CFDA) is proposing to amend its GCP (good clinical practices) to add more specific responsibilities for sponsors, Ethics Committees (ECs) and sites as part of efforts to further protect study subjects, experts say.
In its first earnings call since launching its IPO (initial public offering) in November, PRA Health Sciences reported consistent growth over last year.
CRO Covance's stockholders voted Wednesday to adopt the previously announced $6.1bn merger agreement providing for the acquisition of Covance by LabCorp at the special meeting of Covance stockholders.
CRO Parexel on Wednesday announced the expansion of its clinical trial site alliance network, which includes investigator sites and Site Management Organizations (SMOs) that help the company quickly access and enroll patient populations for clients’ clinical...
China-based CRO WuXi PharmaTech has entered into a syndicated loan facility to borrow up to $165m from a consortium of banks in Asia to seek out new acquisitions.
The US FDA is looking to set up master protocols that can continuously run and help cut down on waste that’s prevalent in the clinical trial industry, Director of FDA's Center for Drug Evaluation and Research Janet Woodcock said in an interview.
CRO inVentiv Health announced late last week new plans to open a Phase I/IIA clinic in Miami, thereby expanding its early phase clinical services to the US.
As the world’s largest CRO continues to snap up market share, CEO Tom Pike is questioning how smaller CROs will compete given the expertise and geographical breadth of their larger peers.
US FDA inspections that uncover significant departures from good clinical practice are seldom included in peer-reviewed literature, according to a new study published in JAMA’s Internal Medicine.
The EMA has defended its decision to redact three Humira clinical study reports, arguing that the information held back was ‘commercially confidential.’
Researchers from the Oncology Department of Tianjin Medical University Cancer Hospital in China recently published a study in Advanced Functional Materials announcing the creation of a new nano-carrier for pancreatic cancer treatments.
CRO consolidation continues with Rockville, MD-based Accelovance expanding its footprint into Europe with the acquisition of Cambridge, UK-based Altair Clinical.
Being a drug developer not just a service provider differentiates Simbec-Orion from the Big CROs according to CEO Ronald Openshaw, whose firm signed two strategic partnerships last week.
Covance’s 5% revenue growth and a book-to-bill ratio of 1.3 for the fourth quarter 2014 was better than anticipated and an encouraging sign for LabCorp, an analyst says.
Improving investigative site relationships in 2015 is a top priority for pharma and CRO (contract research organization) execs, according to a roundtable recently hosted by the Tufts Center for the Study of Drug Development.
In what was largely a pep rally for science, President Obama on Friday unveiled his $215m precision medicine initiative before a crowd of industry, government and academic scientists and congressmen.
The Association of Clinical Research Organizations (ACRO) is bringing in BioClinica as a regular member and Theorem Clinical Research as an associate member.
One quarter after announcing a disappointing book-to-bill ratio, CRO Parexel has now renewed its strategic partnership with GlaxoSmithKline and seen its book-to-bill ratio jump to its highest level since 2012.
The strengthening US Dollar will reduce CRO revenues, say analysts, but firms which have global strategic deals could benefit from reduced operational costs.
update - GVK is 'respectful' of EMA recommendation and is working with customers
ImmuPharma and the recently formed CRO Simbec-Orion Group have entered into a collaboration to run a Phase III clinical study of the potential lupus treatment Lupuzor. Financial terms of the agreement were not released.
Sydney-based contract research organization Novotech has expanded its Hong Kong operations with a new permanent office and prospects for four more staffers to meet the increasing demand in the research market.
The US National Institutes of Health (NIH) has awarded funding to a third organisation performing early-stage clinical trials of infectious disease drugs.
Competition among small CROs kept prices steady in 2014 despite higher sponsor R&D spending and greater outsourcing penetration, according to a Citi Research survey.
Quintiles has said Pfizer will “remain a customer” after analysts said the CRO lost out to a privately-owned contractor in the race to be the drug giant's third alliance partner.
Big pharma and CROs looking to exploit wearable technology in clinical trials will need to overcome reliability and regulatory problems, says an expert.
The US Institute of Medicine has come out strongly in favour of sharing clinical trial results and says funding should be withheld from studies which do not make data public.
With a three-year growth rate of 348% and the addition of over 450 jobs from 2012 to 2014, CRO Clinipace is now chasing acquisitions after closing a $50m round of debt and equity financing.
Southern California-based CRO WCCT Global is collaborating with the National Institute of Allergy and Infectious Diseases (NIAID) on influenza research.
As the second-largest central labs provider in the world, Quintiles is looking at the LabCorp acquisition of the world’s leading central labs provider Covance as a way to potentially nab more market share.
2015 is the year that AMRI loses its royalties for discovering the API of Allegra and the company is now looking to its string of recent acquisitions and new contract revenue to offset the loss.
Quintiles subsidiary Novella Clinical and the academic research arm of the Cardiovascular Research Foundation (CRF) are collaborating to offer pre-clinical to post-market trial services to developers of cardiovascular drugs and devices.
PPD’s recently acquired biotech company X-Chem is launching a multi-target collaboration with Janssen Biotech. Financial terms of the deal were not disclosed.
CROs are due to see an increasing workload in 2015, though the way they conduct trials with partners may continue to shift, according to the Tufts Center for the Study of Drug Development’s Outlook for 2015.
Japan was involved in fewer drug industry-sponsored multi-regional clinical trials (MRCT) in 2014 than any year since 2008 according to the Pharmaceuticals and Medical Devices Agency (PDMA).
